138 related articles for article (PubMed ID: 15161026)
21. Overexpression of Jun activation domain-binding protein 1 in nonsmall cell lung cancer and its significance in p27 expression and clinical features.
Osoegawa A; Yoshino I; Kometani T; Yamaguchi M; Kameyama T; Yohena T; Maehara Y
Cancer; 2006 Jul; 107(1):154-61. PubMed ID: 16721818
[TBL] [Abstract][Full Text] [Related]
22. Decreased level of the cell cycle regulator p27 and increased level of its ubiquitin ligase Skp2 in endometrial carcinoma but not in normal secretory or in hyperstimulated endometrium.
Lahav-Baratz S; Ben-Izhak O; Sabo E; Ben-Eliezer S; Lavie O; Ishai D; Ciechanover A; Dirnfeld M
Mol Hum Reprod; 2004 Aug; 10(8):567-72. PubMed ID: 15220466
[TBL] [Abstract][Full Text] [Related]
23. [Expression of cell cycle-regulatory proteins in squamous cell carcinoma of the esophagus].
Huang JX; Song ZX; Qian RY; Xu GW
Ai Zheng; 2003 Mar; 22(3):277-81. PubMed ID: 12654186
[TBL] [Abstract][Full Text] [Related]
24. Skp2 overexpression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas.
Huang HY; Kang HY; Li CF; Eng HL; Chou SC; Lin CN; Hsiung CY
Clin Cancer Res; 2006 Jan; 12(2):487-98. PubMed ID: 16428491
[TBL] [Abstract][Full Text] [Related]
25. A novel route for connexin 43 to inhibit cell proliferation: negative regulation of S-phase kinase-associated protein (Skp 2).
Zhang YW; Nakayama K; Nakayama K; Morita I
Cancer Res; 2003 Apr; 63(7):1623-30. PubMed ID: 12670914
[TBL] [Abstract][Full Text] [Related]
26. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
Auld CA; Fernandes KM; Morrison RF
J Cell Physiol; 2007 Apr; 211(1):101-11. PubMed ID: 17096381
[TBL] [Abstract][Full Text] [Related]
27. COX-2 correlates with F-box protein, Skp2 expression and prognosis in human gastric carcinoma.
Honjo S; Kase S; Osaki M; Ardyanto TD; Kaibara N; Ito H
Int J Oncol; 2005 Feb; 26(2):353-60. PubMed ID: 15645119
[TBL] [Abstract][Full Text] [Related]
28. The F-box protein SKP2 binds to the phosphorylated threonine 380 in cyclin E and regulates ubiquitin-dependent degradation of cyclin E.
Yeh KH; Kondo T; Zheng J; Tsvetkov LM; Blair J; Zhang H
Biochem Biophys Res Commun; 2001 Mar; 281(4):884-90. PubMed ID: 11237742
[TBL] [Abstract][Full Text] [Related]
29. Cell cycle inhibitory protein p27 in esophageal squamous cell carcinoma.
Ohashi Y; Sasano H; Yamaki H; Shizawa S; Shineha R; Akaishi T; Satomi S; Nagura H
Anticancer Res; 1999; 19(3A):1843-8. PubMed ID: 10470125
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical study of Skp2 and Jab1, two key molecules in the degradation of P27, in lung adenocarcinoma.
Goto A; Niki T; Moriyama S; Funata N; Moriyama H; Nishimura Y; Tsuchida R; Kato JY; Fukayama M
Pathol Int; 2004 Sep; 54(9):675-81. PubMed ID: 15363035
[TBL] [Abstract][Full Text] [Related]
31. Significance of immunohistochemical expression of p27 and involucrin as the marker of cellular differentiation of squamous cell carcinoma of the esophagus.
Nozoe T; Oyama T; Takenoyama M; Hanagiri T; Sugio K; Yasumoto K
Oncology; 2006; 71(5-6):402-10. PubMed ID: 17878746
[TBL] [Abstract][Full Text] [Related]
32. [Effect of Skp2 antisense oligodeoxynucleotide on growth and proliferation of K562 cells].
Wang XZ; Feng WL; Liu X; Cao WX; Huang ZG
Ai Zheng; 2003 Sep; 22(9):948-53. PubMed ID: 12969527
[TBL] [Abstract][Full Text] [Related]
33. Low p27Kip1 expression is associated with poor prognosis in oral squamous cell carcinoma.
Harada K; Supriatno ; Yoshida H; Sato M
Anticancer Res; 2002; 22(5):2985-9. PubMed ID: 12530030
[TBL] [Abstract][Full Text] [Related]
34. Expression of cyclin D1, CDK4 and p27KIP1 is associated with the p16MTS1 gene status in human esophageal carcinoma cell lines.
Kitahara K; Yasui W; Yokozaki H; Semba S; Hamamoto T; Hisatsugu T; Tahara E
J Exp Ther Oncol; 1996 Jan; 1(1):7-12. PubMed ID: 9414383
[TBL] [Abstract][Full Text] [Related]
35. p27KIP1-expression in human renal cell cancers: implications for clinical outcome.
Anastasiadis AG; Calvo-Sanchez D; Franke KH; Ebert T; Heydthausen M; Schulz WA; Burchardt M; Gerharz CD
Anticancer Res; 2003; 23(1A):217-21. PubMed ID: 12680216
[TBL] [Abstract][Full Text] [Related]
36. Degradation of Tob1 mediated by SCFSkp2-dependent ubiquitination.
Hiramatsu Y; Kitagawa K; Suzuki T; Uchida C; Hattori T; Kikuchi H; Oda T; Hatakeyama S; Nakayama KI; Yamamoto T; Konno H; Kitagawa M
Cancer Res; 2006 Sep; 66(17):8477-83. PubMed ID: 16951159
[TBL] [Abstract][Full Text] [Related]
37. The prognostic impact of the ubiquitin ligase subunits Skp2 and Cks1 in colorectal carcinoma.
Shapira M; Ben-Izhak O; Linn S; Futerman B; Minkov I; Hershko DD
Cancer; 2005 Apr; 103(7):1336-46. PubMed ID: 15717322
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of the F-box proteins Skp2 and Skp2B in breast cancer.
Radke S; Pirkmaier A; Germain D
Oncogene; 2005 May; 24(21):3448-58. PubMed ID: 15782142
[TBL] [Abstract][Full Text] [Related]
39. Relationship between levels of Skp2 and P27 in breast carcinomas and possible role of Skp2 as targeted therapy.
Zheng WQ; Zheng JM; Ma R; Meng FF; Ni CR
Steroids; 2005 Oct; 70(11):770-4. PubMed ID: 16024059
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of Skp2 and p27 in human breast cancer.
Traub F; Mengel M; Lück HJ; Kreipe HH; von Wasielewski R
Breast Cancer Res Treat; 2006 Sep; 99(2):185-91. PubMed ID: 16636894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
